CymaBay Therapeutics, Inc.
CBAYDelisted Mar 22, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042074
CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding CymaBay Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 189 | 2 | 200 | +13 |
| Shares | 108.3M | 22.6K | 114.8M | +6.51M (+6.0%) |
| Value | $1.61B | $337.2K | $2.71B | +$1.10B (+67.9%) |
2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (46)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (33)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
Not filed for Q4 2023 yet (2)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Connacht Asset Management LP | 11,986 | $178.7K |
| First Republic Investment Management, Inc. | 10,627 | $158.4K |